Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Sanders pushes subpoena vote to force testimony of Novo Nordisk exec on GLP-1 prices
11 months ago
FDA+
Law
Verily gets into the GLP-1 business with new program to manage cardiac and metabolic conditions
11 months ago
Startups
Health Tech
Ipsen and Genfit secure FDA thumbs up for rare liver disease asset
11 months ago
FDA+
FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay
11 months ago
FDA+
Paxlovid did not beat placebo in Stanford-led long Covid study
11 months ago
R&D
FDA establishes new meeting type to advise on drug safety technology
11 months ago
FDA+
EU launches two advice pilots for clinical trial applications as part of R&D push
11 months ago
GSK wins expanded FDA approval for RSV shot in at-risk adults ages 50 to 59
11 months ago
FDA+
Federal judge dismisses antitrust claims brought against Bristol Myers by insurers
11 months ago
Law
FDA greenlights Geron’s imetelstat to treat anemia in certain cancer patients
11 months ago
FDA+
Italian antitrust agency investigates Novartis, Biogen and others over Lucentis biosimilar
11 months ago
FDA+
Senate fails to pass bill codifying access to contraception
11 months ago
FDA+
FDA explains why it rejected Vanda's insomnia application as company faces takeover bid
11 months ago
FDA+
Safety, efficacy and dosing questions linger for Lilly's Alzheimer's drug ahead of Monday adcomm
11 months ago
FDA+
Nine years and four generics later, the HIV drug at the center of the Shkreli controversy still has a high price
11 months ago
AbbVie gets first taste of Elahere potential with new mid-stage win
11 months ago
R&D
J&J’s dealmaker: Plenty of ‘firepower,’ but mostly focused on tuck-in M&A
11 months ago
Deals
Lilly exec says developing new therapies for lupus is 'in scope'
11 months ago
R&D
Senate Finance Chair presses HHS to crack down on cybersecurity in wake of UnitedHealth attack
11 months ago
FDA+
Health Tech
Oregon jury says J&J owes talc claimant $260M
11 months ago
Law
Lykos’ MDMA-assisted therapy stumbles at adcomm amid questions about study, safety and abuse
11 months ago
FDA+
House lawmakers float transparency reforms for 340B program at hearing
11 months ago
FDA+
UK's NICE recommends Lilly's Zepbound for weight loss
11 months ago
Novo Holdings’ head of Asia on investing in ‘China for China,’ and staying out of biotech (for now)
11 months ago
Financing
China
First page
Previous page
49
50
51
52
53
54
55
Next page
Last page